Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I David Goldman

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Membrane transport of chemotherapeutics and drug resistance: beyond the ABC family of exporters to the role of carrier-mediated processesI David Goldman
The Oncologist|June 1, 2004
Enter Alimta: a new generation antifolateRongbao Zhao, I David Goldman
Oncogene|October 25, 2003
Resistance to antifolatesRongbao Zhao, I David Goldman
Seminars in Oncology|February 7, 2003
Molecular, biochemical, and cellular pharmacology of pemetrexedI David Goldman, Rongbao Zhao
Cancer Metastasis Reviews|March 7, 2007
The molecular identity and characterization of a Proton-coupled Folate Transporter--PCFT; biological ramifications and impact on the activity of pemetrexedRongbao Zhao, I David Goldman
Molecular Aspects of Medicine|March 20, 2013
Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptorsRongbao Zhao, I David Goldman
Current Opinion in Pharmacology|January 3, 2014
The proton-coupled folate transporter: physiological and pharmacological rolesRongbao Zhao, I David Goldman
Annual Review of Pharmacology and Toxicology|January 7, 2015
A conversation with Susan Band HorwitzSusan Band Horwitz, I David Goldman
The New England Journal of Medicine|January 21, 2026
Cerebral Folate Deficiency, Autism, and the Role of LeucovorinI David Goldman, Bruce A Chabner
The Journal of Biological Chemistry|February 9, 2025
Mechanistic insights into mutation in the proton-coupled folate transporter (SLC46A1) causing hereditary folate malabsorptionPrithviraj Nandigrami, I David Goldman, Andras Fiser
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Membrane transport of chemotherapeutics and drug resistance: beyond the ABC family of exporters to the role of carrier-mediated processesI David Goldman
The Oncologist|June 1, 2004
Enter Alimta: a new generation antifolateRongbao Zhao, I David Goldman
Oncogene|October 25, 2003
Resistance to antifolatesRongbao Zhao, I David Goldman
Seminars in Oncology|February 7, 2003
Molecular, biochemical, and cellular pharmacology of pemetrexedI David Goldman, Rongbao Zhao
Cancer Metastasis Reviews|March 7, 2007
The molecular identity and characterization of a Proton-coupled Folate Transporter--PCFT; biological ramifications and impact on the activity of pemetrexedRongbao Zhao, I David Goldman
Molecular Aspects of Medicine|March 20, 2013
Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptorsRongbao Zhao, I David Goldman
Current Opinion in Pharmacology|January 3, 2014
The proton-coupled folate transporter: physiological and pharmacological rolesRongbao Zhao, I David Goldman
Annual Review of Pharmacology and Toxicology|January 7, 2015
A conversation with Susan Band HorwitzSusan Band Horwitz, I David Goldman
The New England Journal of Medicine|January 21, 2026
Cerebral Folate Deficiency, Autism, and the Role of LeucovorinI David Goldman, Bruce A Chabner
The Journal of Biological Chemistry|February 9, 2025
Mechanistic insights into mutation in the proton-coupled folate transporter (SLC46A1) causing hereditary folate malabsorptionPrithviraj Nandigrami, I David Goldman, Andras Fiser
Pageof 8